A Rare Case Of Synchronous Multiple Primary Lung Cancer With Different Responses To Gefitinib
RESPIRATORY MEDICINE CASE REPORTS(2020)
摘要
Differentiating multiple primary lung cancer (MPLC) from lung metastasis is important, and the pathology and gene mutations may be different between the tumors. A lung biopsy to differentiate lesions should be considered, especially when the response of different tumors to treatment is distinct.
更多查看译文
关键词
Lung cancer, Multiple primary, Synchronous, Gefitinib
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要